Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Nitric oxide synthase inhibitors described by Hoechst

Aug. 9, 1996

FDA clears Mylan's nicardipine HCl

Aug. 9, 1996

UCB reports alpha-adrenergic ligands with cardiovascular activity

Aug. 9, 1996

Biovail's diltiazem covered under U.S. patent

Aug. 9, 1996

Status update of Recordati's lercanidipine HCl

Aug. 9, 1996

SmithKline Beecham and Meiji Seika to comarket levcromakalim

Aug. 9, 1996

Eisai terminates E-4177 development

Aug. 9, 1996

Renin inhibitors described by Ciba-Geigy

Aug. 9, 1996

KRH-594: Wakunaga's angiotensin II antagonist

Aug. 9, 1996

Angiotensin II antagonists disclosed by Tanabe Seiyaku

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...